Therefore, the objective of the present study is to test the hypothesis that SFN might regulate IAA and gut microbiota in HFD-fed mice and prevent NAFLD through activating AHR/SREBP-1C pathway. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.